Importantly, a meta-analysis demonstrated that in addition to prostate cancer, the mRNA expression of HSF2 is downregulated in a variety of cancer tissues [88], suggesting that HSF2 downregulation is a key event during cancer development. This evidence concerns the gene HSF2 and prostate cancer.